Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.8181
+0.0438 (5.66%)
At close: May 12, 2025, 4:00 PM
0.8300
+0.0119 (1.45%)
After-hours: May 12, 2025, 7:52 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $76.09 million as of May 12, 2025. Its market cap has decreased by -78.12% in one year.
Market Cap
76.09M
Enterprise Value
-110.14M
1-Year Change
-78.12%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $76.09M, a decrease of -91.44%. That is a compound annual growth rate of -47.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 72.01M | -49.98% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |